Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 15 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

5 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

Phase 4

4(36.4%)

N/A

4(36.4%)

Phase 3

1(9.1%)

Phase 1

1(9.1%)

Phase 2

1(9.1%)

11Total

Phase 4(4)

N/A(4)

Phase 3(1)

Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT05392764Phase 3Recruiting

Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure

Role: lead

NCT07397650Phase 4Recruiting

Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure

Role: lead

NCT07196033Recruiting

Asian Gynecological Brachytherapy Registry in Cervical Cancer

Role: collaborator

NCT05258279Phase 2Active Not Recruiting

Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations

Role: lead

NCT02324283Not ApplicableActive Not Recruiting

Comparison of Emergence and Oxygenation During One-lung Ventilation With Desflurane and Propofol Anesthesia

Role: lead

NCT04950842Phase 1Active Not Recruiting

Induction of Transplant Tolerance in LDLT Via iTS

Role: lead

NCT00242944Phase 4Completed

Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

Role: collaborator

NCT05600478Completed

Physical Therapy in the Intensive Care Unit: A Comparative Study of Three Asian Countries

Role: collaborator

NCT03019887Not ApplicableCompleted

Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction

Role: lead

NCT01042730Not ApplicableCompleted

Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

Role: lead

NCT00294567Phase 4Completed

Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)

Role: lead

NCT04053998Completed

Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.Org

Role: collaborator

NCT04144218Phase 4Unknown

Evaluation of the Efficacy and Safety of Lacosamide in Pediatric Patients With Epilepsy

Role: collaborator

NCT02907229Not ApplicableCompleted

Safety and Efficacy of Honeycomb Microporous Covered Stents (NCVC-CS1) for the Treatment of Intracranial Aneurysms

Role: collaborator

NCT03577015Unknown

International Prospective Registry of Disseminated Intravascular Coagulation

Role: collaborator

All 15 trials loaded